Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,735 public trials 964 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

NCT00031187

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • West Los Angeles - VA Healthcare Center Los Angeles, California, United States
  • VA Medical Center of Palo Alto Palo Alto, California, United States
View Trial Details
Completed

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

NCT00005857

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • St. Elizabeth's Medical Center of Boston Brighton, Massachusetts, United States
View Trial Details
Completed

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

NCT00992745

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • West Coast Radiology Centers Laguna Niguel, California, United States
  • Pacific Coast Imaging Newport Beach, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

NCT00712829

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Johns Hopkins Medical Institutes - Neuroradiology Division Baltimore, Maryland, United States
  • New York Weill Cornell Medical Center - New York Presbyterian Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions